- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Kyowa Kirin Pharmaceutical Development Ltd
Total 323 results
-
Kyowa Kirin, Inc.Completed
-
Kyowa Kirin, Inc.CompletedParkinson's DiseaseUnited States
-
Kyowa Kirin, Inc.Kyowa Kirin Co., Ltd.CompletedSleep Disorder | Restless Legs SyndromeUnited States
-
Kyowa Kirin, Inc.CompletedCarcinoma | Cancer | Solid TumorUnited States, France
-
Kyowa Kirin, Inc.TerminatedUrothelial CarcinomaUnited States, Spain
-
Kyowa Kirin, Inc.AstraZenecaCompletedAdvanced Solid TumorsUnited States
-
Kyowa Kirin Korea Co., Ltd.RecruitingHyperphosphatemiaKorea, Republic of
-
Kyowa Kirin Korea Co., Ltd.CompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
Kyowa Kirin Korea Co., Ltd.TerminatedPhase 1 Portion : Non Small Cell Lung Cancer(NSCLC), Small Cell Lung Cancer(SCLC), Mesothelioma | Phase 2 Portion : Small Cell Lung Cancer(SCLC)Korea, Republic of
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin UK, Ltd.CompletedMultiple Myeloma | Chronic Lymphocytic Leukaemia | B-cell Non-Hodgkin's LymphomaUnited Kingdom
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin UK, Ltd.CompletedParkinson's DiseaseUnited Kingdom
-
Kyowa Kirin Korea Co., Ltd.CompletedAplastic AnemiaKorea, Republic of
-
Kyowa Kirin Co., Ltd.TerminatedAcute Myelogenous Leukemia (AML)United States
-
Kyowa Kirin Co., Ltd.CompletedHyperphosphatemiaJapan
-
Kyowa Kirin Co., Ltd.TerminatedDiabetic Kidney DiseaseJapan
-
Kyowa Kirin Co., Ltd.CompletedHealthy Men and Subjects With Ulcerative ColitisJapan
-
Kyowa Kirin Co., Ltd.Active, not recruitingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Indolent B-cell Non-Hodgkin's LymphomaJapan
-
Kyowa Kirin Co., Ltd.CompletedHyperphosphatemiaJapan
-
Kyowa Kirin Co., Ltd.Active, not recruitingRelapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.CompletedPeripheral Blood Stem Cell TransplantationJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.CompletedParkinson's DiseaseJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.CompletedAlzheimer DiseaseJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.TerminatedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.TerminatedNon-small-cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.CompletedMDSJapan, Korea, Republic of
-
Kyowa Kirin Co., Ltd.CompletedUncontrolled and Suspected Eosinophilic AsthmaKorea, Republic of, Japan
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Kirin Co., Ltd.Completed
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Canada
-
Kyowa Hakko Kirin UK, Ltd.CompletedCongenital Antithrombin DeficiencyFrance, Germany, Italy, Sweden, United Kingdom
-
Kyowa Hakko Kirin Pharma, Inc.Kyowa Kirin Co., Ltd.CompletedX-linked HypophosphatemiaUnited States, Canada
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.TerminatedColorectal CancerUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.TerminatedNeoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms | Primary Peritoneal NeoplasmUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.TerminatedBreast CancerUnited States
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.Completed
-
Ultragenyx Pharmaceutical IncKyowa Kirin Co., Ltd.AvailableX-linked Hypophosphatemia | Tumor-Induced Osteomalacia